Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
dose-response shift
Description:
A change in the dose-response relationship, such as altered potency or sensitivity, resulting in different doses producing comparable effects.
Related topics:
Neurotransmitter Receptor Influence on Behavior (16%),
Receptor Mechanisms and Signaling (11%),
Neuropeptides and Animal Physiology (9%),
Pain Mechanisms and Treatments (8%)
OpenAlex ID:
keywords/dose-response-shift
Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
1997
·
Ichiro Sora
, Nobuyuki Takahashi
, et al.
·
Proceedings of the National Academy of Sciences
·
571
Quantitative studies on some antagonists of N‐methyl D‐aspartate in slices of rat cerebral cortex
1985
·
Neil L. Harrison
, Michael A. Simmonds
·
British Journal of Pharmacology
·
513
PDF
Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
1995
·
Jianren Mao
, Donald D. Price
, et al.
·
Pain
·
343
Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors
1995
·
Cesar Labarca
, Mark W. Nowak
, et al.
·
Nature
·
327
Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
1985
·
G S Ling
, K Spiegel
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
315
Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
1991
·
A Mattia
, T Vanderah
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
248
Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
1990
·
E Meller
, M Goldstein
, et al.
·
Molecular Pharmacology
·
244
Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways.
1987
·
S Wigdor
, G L Wilcox
·
Journal of Pharmacology and Experimental Therapeutics
·
236
Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
1992
·
S P Welch
, D L Stevens
·
Journal of Pharmacology and Experimental Therapeutics
·
227
Antispasmodic Effects of Some Medicinal Plants
1980
·
H. Forster
, H. Niklas
, et al.
·
Planta Medica
·
222
Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonist
1989
·
John L. Waddington
, Kathy M. O'Boyle
·
Pharmacology & Therapeutics
·
215
Serotonergic mechanisms in the behavioral effects of buspirone and gepirone
1986
·
Arlene S. Eison
, Michael S. Eison
, et al.
·
Pharmacology Biochemistry and Behavior
·
203
The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating.
1995
·
G N Filatov
, M M White
·
Molecular Pharmacology
·
190
Cocaine vaccines: Antibody protection against relapse in a rat model
2000
·
M. Rocío A. Carrera
, Jon A. Ashley
, et al.
·
Proceedings of the National Academy of Sciences
·
171
Interaction of Intrathecal Morphine with Bupivacaine and Lidocaine in the Rat
1992
·
John P. Penning
, Tony L. Yaksh
·
Anesthesiology
·
153
Rapid compensatory changes in GABA receptor efficacy in rat vestibular neurones after unilateral labyrinthectomy
2000
·
Toshiaki Yamanaka
, Aydin Him
, et al.
·
The Journal of Physiology
·
150
Enhancement of μ Opioid Antinociception by Oral Δ9-Tetrahydrocannabinol: Dose-Response Analysis and Receptor Identification
1999
·
Diana L. Cichewicz
, Zachary L. Martin
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
149
Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
1994
·
P B Smith
, S P Welch
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
147
New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity.
1985
·
F Makovec
, R Chistè
, et al.
·
PubMed
·
144
ARA9 Modifies Agonist Signaling through an Increase in Cytosolic Aryl Hydrocarbon Receptor
2000
·
John J. LaPres
, Edward Glover
, et al.
·
Journal of Biological Chemistry
·
143
Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: The case of the aryl hydrocarbon receptor
2005
·
A OKEY
, M FRANC
, et al.
·
Toxicology and Applied Pharmacology
·
139
Induction of Metallothionein as an Adaptive Mechanism Affecting the Magnitude and Progression of Toxicological Injury
1998
·
C D Klaassen
, J Liu
·
Environmental Health Perspectives
·
138
PDF
The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex
1994
·
A. Ceci
, A. Baschirotto
, et al.
·
Neuropharmacology
·
137
A nicotinic acetylcholine receptor mutation (Y151S) causes reduced agonist potency to a range of neonicotinoid insecticides
2006
·
Zewen Liu
, Martin S. Williamson
, et al.
·
Journal of Neurochemistry
·
135
Loss of Peripheral Morphine Analgesia Contributes to the Reduced Effectiveness of Systemic Morphine in Neuropathic Pain
2004
·
Md Harunor Rashid
, Makoto Inoue
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
134
Show more works
View as search
Works count:
710
Citation count:
21,430
Year
Topic
Type